← Back to headlines
Guardant Health Projects 27-30% Revenue Growth for 2026
Guardant Health anticipates 27-30% revenue growth for 2026, fueled by the expansion of its Shield and oncology portfolio.
20 Feb, 01:15 — 20 Feb, 01:15
Sources
Showing 1 of 1 sources
Related Stories
Iran Claims Sufficient Foreign Reserves Despite US Sanctions
14m ago
Eurozone Inflation Climbs to 3.3%, Boosting Expectations for ECB Rate Hikes
44m ago
Fed Chair Warsh Addresses Market Uncertainties Following Jackson Hole Symposium
1h ago
UK Government Borrowing Costs Hit 28-Year High Ahead of Budget
2h ago